Clinicopathological features and types of microsatellite instability in 1394 patients with colorectal cancer.
10.12122/j.issn.1673-4254.2020.11.17
- Author:
Xiangzhao LI
1
;
Huanjiao LIU
1
;
Minyi LIANG
1
;
Huihui CHEN
1
;
Li LIANG
1
Author Information
1. Department of Pathology, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
- Publication Type:Journal Article
- Keywords:
colorectal cancer;
immunohistochemistry;
microsatellite instability;
mismatch repair;
polymerase chain reaction-capillary electrophoresis
- MeSH:
China;
Colorectal Neoplasms/genetics*;
DNA Mismatch Repair/genetics*;
Humans;
Microsatellite Instability
- From:
Journal of Southern Medical University
2020;40(11):1645-1650
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To explore the clinicopathological features and types of genic mutations in DNA mismatch repair (MMR) in colorectal cancer (CRC).
METHODS:Immunohistochemistry was used to determine the expression of MMR proteins in 1394 patients with CRC, and PCR-capillary electrophoresis (PCR-CE) was used to detect microsatellite instability (MSI) in 106 cases of defective MMR (dMMR), 46 cases of proficient MMR (pMMR) with heterogeneous expression and 147 randomly selected cases of pMMR. The relationship between the expressions of MMR proteins and the clinicopathological features of the patients was evaluated. The consistency between the results of immunohistochemistry and PCR-CE was assessed.
RESULTS:Immunohistochemical staining showed an incidence of dMMR of 7.6% in the patients. The main type of dMMR was co-deletion of MLH1 and PMS2, accounting for 55.7% of the total dMMR cases. The deletion of MMR proteins was significantly correlated with the patients' age, tumor location, tumor size, gross type, histological type, degree of differentiation, lymph node status and TNM stage (
CONCLUSIONS:The main type of dMMR is co-deletion of MLH1 and PMS2 in patients with colorectal cancer. dMMR colorectal cancer has typical clinicopathological features and a lower incidence in China than in Western countries. The results of immunohistochemistry and PCR-CE are highly consistent for detecting dMMR in colorectal cancer patients.
